OSUR, US68554V1089

OraSure Technologies stock gets fresh insider grant of 4,797 shares

Published on 10/08/2026 at 01:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue was USD 30.64 million on June 30, 2026, down 1.9 percent year over year. Nasdaq closed at USD 3.73 on October 7, 2026.

OSUR, US68554V1089, Illustration mit AI erstellt.
OSUR, US68554V1089, Illustration mit AI erstellt.

OraSure Technologies (ISIN US68554V1089) closed at USD 3.73 on Nasdaq on October 7, 2026, down 1.06 percent from the prior session. The latest company-specific filing reports a 4,797-share director grant dated September 29, 2026, filed on October 1.

Director grant adds an insider signal

According to StockTitan, director Steven Kyle Boyd received 4,797 restricted common shares at USD 3.88 per share on September 29, 2026. The filing states that the award vested immediately and replaced cash director fees under the company compensation policy.

Boyd held 168,031 shares directly after the grant, according to StockTitan. The transaction is compensation-related, so its signal differs from an open-market purchase.

Revenue falls 1.9 percent

OraSure reported USD 30.64 million of revenue for the quarter ended June 30, 2026, down 1.9 percent from the year-earlier quarter, while diluted EPS was USD 0.09, according to ToAlpha. The same quarter produced a 43.5 percent gross margin and a 17.8 percent operating margin.

The company describes its business as rapid diagnostic tests and sample collection and stabilization devices serving clinical, public-health, research and direct-to-consumer markets, according to OraSure Technologies. That mix leaves quarterly revenue and cash generation central to the stock narrative.

Stock stays below yearly high

At USD 3.73 on October 7, 2026, OraSure Technologies stock stood below its Nasdaq 52-week high of USD 4.58 and above its low of USD 2.08. The session range was USD 3.63 to USD 3.86, with volume of 435,000 shares.

Market capitalization was USD 260.0 million on October 7, 2026. The valuation remains tied to a company that held USD 160.6 million in cash at June 30, 2026, while operating cash flow for the quarter was negative USD 9.9 million.

OraSure Technologies stock at USD 3.73

OraSure Technologies stock closed at USD 3.73 on Nasdaq on October 7, 2026, after the 1.06 percent daily decline. The director grant, second-quarter revenue trend and cash position define the next checkpoints for the shares.

OraSure Technologies stock facts

  • Company: OraSure Technologies, Inc.
  • ISIN: US68554V1089
  • Ticker: OSUR
  • Trading venue: Nasdaq
  • Price (as of October 7, 2026): USD 3.73, closing price
  • Market capitalization: USD 260.0 million (as of October 7, 2026)
  • 52-week range: USD 2.08-4.58 (as of October 7, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

More news and analysis on OraSure Technologies stock

Disclaimer...

en | US68554V1089 | OSUR | boerse | 70260072 | bgmi